This is a research prototype. The data and analyses are preliminary and not yet validated — we'd welcome your .
The Acclarent TruDi Navigation System, an AI-enhanced medical device for sinus surgery, has been linked to multiple reports of patient injury, including carotid-artery damage and strokes. Lawsuits allege that the system's AI misinformed surgeons about the location of their instruments during procedures. While the manufacturer denies a causal link, the incidents highlight broader concerns regarding the safety and regulatory oversight of AI-enabled medical devices.
During a reported sinus procedure in Texas, Acclarent's AI-enabled TruDi Navigation System was alleged to have misinformed surgeon Marc Dean about the position of his instruments inside patient Erin Ralph's head, purportedly contributing to carotid-artery injury and a stroke. Reuters reported that Ralph later sued, alleging the system's AI contributed to her injuries. Acclarent and Integra denied a causal connection.
Domain classification, causal taxonomy, severity scores, and national security assessments were LLM-classified and may contain errors.
AI systems that fail to perform reliably or effectively under varying conditions, exposing them to errors and failures that can have significant consequences, especially in critical applications or areas that require moral reasoning.
Also classified as
The report highlights that the FDA is struggling to keep pace with AI medical devices due to staff cuts and an outdated regulatory framework.
The TruDi system failed to perform reliably, misinforming surgeons about instrument locations and leading to severe surgical errors and patient injuries.
AI system
Due to a decision or action made by an AI system
Unintentional
Due to an unexpected outcome from pursuing a goal
Post-deployment
Occurring after the AI model has been trained and deployed
The physical injuries and malfunctions were caused by the TruDi AI system providing inaccurate navigation data after it was deployed in active surgeries.
Added categories peak at 2: Minor (Psychological Harm, Inferred)
The TruDi surgical navigation system malfunction represents a significant clinical safety and regulatory failure, resulting in patient injuries. However, it lacks national security implications, as it is a localized medical product liability issue manageable under standard FDA and healthcare procedures.
The TruDi system is described as using a machine-learning algorithm to 'assist ear, nose and throat specialists in surgeries' and provide real-time feedback, requiring human oversight and decision-making.
High Risk: The system is an AI-enhanced medical device used in healthcare for surgical navigation, which has significant implications for patient safety.
The system's primary function is to assist surgeons by calculating paths and providing real-time navigation feedback during sinus surgeries.
The report provides detailed accounts of specific patient injuries, FDA adverse event statistics, and regulatory context. While the manufacturer disputes causality, the occurrence of the malfunctions and injuries is well-documented through FDA reports and lawsuits.
The injuries could be attributed entirely to human surgeon error rather than AI malfunction, as argued by the manufacturer.
Technology
80% Accuracy Target
Acclarent set a goal of only 80% accuracy before integrating the AI.
Inaccurate Path Calculation
Algorithm misinformed surgeons about instrument locations during operations.
Human Factors
Surgeon Reliance on AI
Surgeons relied on faulty real-time feedback to position instruments.
Process and Methods
Rushed to Market
Acclarent lowered safety standards to rush the AI technology to market.
No Patient Clinical Trials
FDA rules allowed authorization without testing the AI device on patients.
Management
Prioritizing Marketing Over Safety
AI was pushed primarily as a marketing tool to claim novel technology.
Ignoring Expert Warnings
Management ignored warnings from consulting surgeon about system issues.
Regulatory Environment
FDA Staffing Cuts
DOGE budget cuts laid off key AI scientists, doubling reviewer workloads.
Outdated Regulatory Approach
Traditional FDA framework is not up to task of ensuring AI device safety.
AI system involved
Identified by automated extraction; can differ from the alleged developers above.
